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Rheumatoid arthritisAbstract Objectives: Firstly to assess the prevalence of subclinical atherosclerosis and endothelial
dysfunction by high resolution ultrasound measurements of carotid intima media thickness (CIMT)
and brachial artery ﬂow mediated dilatation percentage (FMD%) in patients with rheumatoid
arthritis (RA), secondly to analyze the correlation of CIMT and FMD% with different clinical
and laboratory parameters, third aim was to analyze the relationship between CIMT and FMD%.
Patients and methods: The prospective case–control study included 50 patients with RA and 50
healthy age and sex matched controls. All participants were subjected to carotid and brachial arter-
ies ultrasound for measuring CIMT and FMD%, in addition to detailed history and physical exam-
ination.ed.
90 M.A. Amin et al.Results: Patients with RA had signiﬁcantly higher CIMT and signiﬁcantly lower FMD% than the
controls (P< 0.001). In RA patients a signiﬁcant correlation was found between CIMT and the
patient’s age, disease duration, systolic blood pressure, HAQ, DAS, CRP and HDL-c, however
no detectable correlation between the brachial artery FMD% and the clinical and laboratory
parameters in RA patients. There was no signiﬁcant correlation between CIMT and FMD%.
Conclusion: FMD% and CIMT are important non-invasive independent imaging methods for
early prediction of subclinical atherosclerosis in RA patients.
 2014 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier
B.V. All rights reserved.1. Introduction
Rheumatoid arthritis (RA) is a systemic autoimmune inﬂam-
matory disease that affects synovial joints and lead to chronic
pain, bone erosions and progressive disability. Approximately
1% of the adult population in the United States has RA, and
the overall world prevalence range from 0.5% to 1%, qualify-
ing it as the most common chronic inﬂammatory condition (1).
Cardiovascular (CV) disease is the most common cause of
mortality in patients with rheumatoid arthritis (RA) with a rel-
ative risk of about 2 compared with age matched controls (2).
The presence of chronic immuno-inﬂammatory process is
responsible for the development of subclinical atherosclerosis
and increased incidence of CV events in these patients (3,4).
Endothelial dysfunction mediated by inﬂammation is
thought to be an important event in early atherogenesis and
also contributes to the development of clinical features in the
later stages of vascular disease including progression of athero-
sclerotic plaque (5).
A noninvasive physiologic technique to test endothelial
function is to assess the post occlusion ﬂow-mediated vasodila-
tion (FMD) of brachial artery using high sensitivity ultraso-
nography (6). In this method, FMD is the response of
endothelium to shear stress induced by reactive hyperaemia.
So FMD is considered endothelium dependent vasodilation
and any impairment of brachial artery FMD is considered a
marker of endothelial dysfunction (7).
Another clinical useful tool indicating subclinical athero-
sclerosis (without clinically evident atherosclerosis e.g. CVDs,
PVD, etc. or its complications) is to measure carotid artery
intima-media thickness (CIMT) with high resolution B-mode
ultrasonography, providing noninvasive anatomic structural
measure of subclinical atherosclerosis (8). It constitutes an
excellent surrogate marker of macrovascular atherosclerotic
disease. This is the most popular technique used to study the
early structural changes in the arterial wall. A number of stud-
ies have proved that carotid intima-media thickness is signiﬁ-
cantly higher in RA patients than in age, sex and
cardiovascular risk factors matched controls (9).
Several studies suggest that CIMT, structural measure of
early atherosclerosis in RA patients and brachial artery
FMD%, a physiologic measure of subclinical atherosclerosis
are reliable methods to assess the subclinical atherosclerosis
and may measure different stages of early atherogenesis in
RA patients (10), so the aim of this study was to assess the
prevalence of subclinical atherosclerosis and endothelial dys-
function by high resolution ultrasound measurement of carotid
intima media thickness (CIMT) and brachial artery ﬂow med-
iated dilatation percentage (FMD%) in RA patients, secondlyto analyze the correlation of the CIMT and FMD% with dif-
ferent clinical & laboratory parameters as well as the relation
between the CIMT and FMD%.2. Patients and methods
2.1. Study participants
This prospective case–control study was performed between
January 2013 and January 2014 on ﬁfty patients (44 females,
6 males) with RA (diagnosed according to the revised Ameri-
can college of Rheumatology –ACR – criteria) (11) who were
referred to the ultrasound unit of the Tanta diagnostic and
medical imaging department from the outpatient clinic of the
rheumatology and Rehabilitation department of the Tanta
university hospitals, their age ranged between 28 and 65 years
with a mean of 42 ± 6.2 years, and the duration of the disease
ranged between 5 and 27 years, another 50 age and sex
matched healthy controls were also included in this study.
Exclusion criteria for both RA patient and control subjects
included hypertension (blood pressure >140/90 mmHg), cur-
rent or history of smoking, diabetes mellitus, hyperlipidaemia,
history of oral contraceptive pills intake, obesity (body mass
index -BMI- P30 kg/m2), chronic medical diseases such as
liver and renal diseases, patients not fulﬁlling the revised
ACR criteria for the diagnosis of RA and clinically manifest
atherosclerosis by the way of CAD, peripheral vascular disease
(PVD), cerebrovascular disease etc.
The institutional ethics committee approved the study pro-
tocol and written consents were taken from all patients and
control groups.
Clinical assessment of both RA patients and control groups
included: BMI, blood pressure, disease activity score (DAS),
disease duration, Health Assessment Questionnaire (HAQ)
score, laboratory investigations included, ESR, RF, CRP, lipid
proﬁle including total cholesterol, high density lipoprotein-
cholesterol (HDL-c), low density lipoprotein-cholesterol
(LDL-c) and triglycerides.
2.2. High resolution B-mode ultrasound assessments
2.2.1. Carotid intima wall thickness
Carotid intima media thickness (CIMT) was measured using a
high resolution B-mode ultrasound machine (Biomedical P-K,
Denmark) equipped with an 11-MHz frequency linear probe,
the procedure was done by the same radiologist on the same
ultrasound machine. All subjects (patients and control) were
examined in supine position, neck extended and chin facing
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examined in both longitudinal and transverse scans, three con-
secutive measurements of intima media thickness were taken
from the far wall of both common carotid arteries, 1–2 cm
proximal to the carotid bulb over the common carotid artery
and in the proximal most portion of the internal carotid artery
near its origin and the average of these 6 measurements from
both sides was taken for ﬁnal statistical analysis. All measure-
ments were made manually.
2.2.2. Measurement of brachial artery ﬂow mediated dilatation
Brachial artery ultrasound study was performed in a quiet,
dark, temperature-controlled room, all the participants were
in supine position, resting for 10 min, and the measurements
of brachial artery were taken in longitudinal scan in the arm
5–10 cm above the antecubital fossa without permanent vascu-
lar access. The luminal diameter of the artery was measured
between the proximal and distal intima. After recording the
baseline diameter of the brachial artery (D0), transient ische-
mia was induced by cuff which was placed around the forearm
and inﬂated to 200 mmHg (or 50 mmHg more than the systolic
blood pressure) for 5 min and the cuff was deﬂated and a sec-
ond scan for arterial diameter measurements was taken about
40–60 s after deﬂation (D1), ﬂow mediated dilatation (FMD)
was expressed as a percentage change in the brachial artery
diameter from the baseline to ischemia (FMD%) and calcu-
lated by the following formula (D1  D0/D0 · 100), and the
higher the percentage value the better the endothelial function.
2.3. Statistical analysis
Analysis was done using SPSS for Windows version 10.0
(SPSS Inc., USA). Data are expressed as mean ± standard
deviation, the differences between patients and controls were
assessed by the X2-test for the comparison of non-numerical
data and by student’s t-test for the comparison of normally
distributed variables. Univariate regression analysis was used
to examine the relationship between the CIMT and FMD%
and several study variables. Regression analysis was used to
study the relationship between the CIMT and FMD% in the
RA patients group with CIMT used as a dependent variable.
Values of P< 0.05 were considered signiﬁcant and those with
P-value > 0.05 were insigniﬁcant.
3. Results
This prospective case–control study was performed on ﬁfty
patients (44 females, 6 males) with RA, with a mean age of
42 years and a mean duration of the disease of 12.4 years,
another 50 age and sex matched healthy controls were also
included in this study.
The clinical and laboratory characteristics of both RA
patients and healthy controls are shown in Table 1. Females
constituted 88% of the 50 patients and 50 controls studied.
Out of the 88 female patients, 52 (59%) were pre-menopausal
and 36 (41%) were post-menopausal. There was no statistically
signiﬁcant difference in the mean of age, BMI, systolic blood
pressure, diastolic blood pressure, and lipid proﬁle of the
patient and control groups. Patients with RA had a signiﬁ-
cantly higher mean values than the controls of both ESR
((27.4 ± 13.1) vs. (9.8 ± 5.3)) and CRP ((16.2 ± 4.6) vs.(3.7 ± 0. 6)) respectively; P< 0.001. Rheumatoid factor was
positive in 42 patients (84%) (Table 1).
Patients with RA had a signiﬁcantly higher CIMT
(0.91 ± 0.19 mm) than the controls (0.58 ± 0.04 mm)
(P< 0.001), however brachial artery FMD% was signiﬁcantly
lower in patients withRA than the control group (5.2 ± 3.11 vs.
10.1 ± 2.6% respectively; P< 0.001) (Table 2, Figs. 1 and 2).
By using the univariate analysis, in RA patients a signiﬁ-
cant positive correlation was found between CIMT and the
patient’s age, disease duration, systolic blood pressure, HAQ,
DAS and CRP and a statistically inverse correlation was
observed between the CIMT and the HDL-c, however no
detectable correlation was found between the brachial
FMD% and the clinical and laboratory parameters in RA
patients (Table 3).
In the RA patients, there was no detectable correlation
between the CIMT (as a dependent variable) (b coefﬁ-
cient = 0.2341, P> 0.05) and the FMD% (as a continuous
variable). No signiﬁcant correlation was found using regres-
sion analysis including age, sex, disease duration, systolic
blood pressure, CRP, DAS and HDL-c (Table 4).4. Discussion
Rheumatoid arthritis (RA) causes signiﬁcant morbidity as a
result of synovial inﬂammation, joint destruction, and associ-
ated disability in addition to these articular manifestations of
RA, there is a growing recognition of an excess mortality
and the most common cause of mortality in RA is cardiovas-
cular disease (12,13).
At present, several noninvasive imaging techniques offer a
unique opportunity to study the relation of surrogate markers
for the development of atherosclerosis. The use of these tech-
niques may help identify high-risk individuals who may beneﬁt
from active therapy to prevent clinical disease (14).
Two important non-invasive techniques were useful in the
assessment of subclinical atherosclerosis, the evaluation of
endothelial function by ﬂow mediated (endothelium depen-
dent) vasodilatation (FMD%) and the measurement of carotid
intima-media thickness (CIMT) by high-resolution B-mode
ultrasonography (15) (Fig. 3).
So in this study we planned to evaluate the extent of the
subclinical atherosclerosis in rheumatoid arthritis patients by
the measurement of the carotid intima media thickness
(CIMT) and brachial artery ﬂow mediated dilatation percent-
age (FMD%) & analyzing the correlation of the CIMT and
FMD% with different clinical & laboratory parameters as well
as the relation between the CIMT and FMD% (Figs. 4–6).
The measurement of CIMT by B-mode high resolution
ultrasonography is a valid noninvasive anatomic structural
method for assessing subclinical asymptomatic atherosclerosis
in the general population (16). CIMT is deﬁned as the width of
the vessel intima and media, which consists of endothelium,
connective tissue and smooth muscle. This is also the site of
lipid deposition and plaque formation (17).
In the present study, we demonstrate that compared with
the healthy control subjects, RA patients had subclinical ath-
erosclerosis in terms of impaired FMD% and increased
CIMT. The clinical factors associated with CIMT were not
all related to FMD%. There is also no relationship between
brachial FMD, a physiologic measure of subclinical
Table 1 Clinical and laboratory characteristics in both rheumatoid arthritis patients and healthy controls.
Parameters Patients (n= 50) Control (n= 50) P-value
Age (years) 42.3 ± 6.2 40.1 ± 5.6 NS
Sex (female/male) 44/6 44/6 NS
BMI (kg/m2) 22.3 ± 2.1 20.5 ± 3.26 NS
Disease duration (years) 12.4 ± 4.6 –
Systolic blood pressure (mmHg) 116 ± 9.3 112 ± 10.2 NS
Diastolic blood pressure (mmHg) 71.34 ± 7.2 70.58 ± 8.4 NS
Total cholesterol (mg/dl) 211.21 ± 23.42 215 ± 22.3 NS
HDL-c (mg/dl) 43.31 ± 5.2 48.7 ± 3.7 NS
LDL-c (mg/dl) 129.2 ± 17.3 128.4 ± 19.6 NS
Triglycerides (mg/dl) 116.61 ± 38.2 119.37 ± 35.2 NS
ESR (mm/h) 27.4 ± 13.1 9.8 ± 5.3 <0.001 (HS)
CRP (mg/dl) 16.2 ± 4.6 3.7 ± 0.6 <0.001 (HS)
RF positivity (n (%)) 42 (84%) – –
DAS 3.49 ± 92 – –
HAQ 1.23 ± 0.62 – –
Values are expressed in mean ± SD, NS= not statistically signiﬁcant, HS = highly signiﬁcant.
Table 2 B-mode ultrasound measurements of the carotid intima media thickness and brachial ﬂow mediated dilatation percentage in
both rheumatoid arthritis patients and healthy controls.
Ultrasound parameters RA patients (n= 50) Controls (n= 50) P-value
CIMT (mm) 0.91 ± 0.19 0.58 ± 0.04 <0.001 (HS)
FMD% 5.2 ± 3.11 10.1 ± 2.6 <0.001 (HS)
Values are expressed in mean ± SD, HS = highly signiﬁcant, CIMT= carotid intima media thickness, FMD%= ﬂow mediated dilatation
percentage.
Fig. 1 Boxplot revealed correlation between mean carotid
intima-media thickness (IMT) of both RA patients & controls
(value are expressed as mean ± SD).
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Boxplot of FMD% in RA vs. Control
P <0.001
Fig. 2 Boxplot revealed correlation between mean percentages
of brachial artery ﬂow mediated vasodilatation (FMD%) of both
patients & controls (value are expressed as mean ± SD).
92 M.A. Amin et al.atherosclerosis and CIMT, a structural measure of early ath-
erosclerosis in RA patients without risk factors for atheroscle-
rosis or clinical evidence of cardiovascular disease. So FMD%
and CIMT may measure a different stage of subclinical athero-
sclerosis in RA patients.
In the current study, RA patients had a signiﬁcantly higher
CIMT (0.91 + 0.19) than the controls (0.58 + 0.04)
(P< 0.001), so our patients, who did not show any evidence
of known atherosclerotic disease, may have subclinical athero-
sclerosis with subsequent higher risk for development of car-
diovascular events. These ﬁndings are consistent with the
results of previous studies (10,18,19).In our study, there were signiﬁcant positive correlations
between the CIMT and patient’s age, disease duration,
systolic blood pressure, HAQ Score, DAS and CRP but
negative correlation was found between the CIMT and
HDL-c. Our results are similar to other studies worldwide
which reported that on multivariate analysis, only age and
disease duration were found to have signiﬁcant correlation
with CIMT (20,21).
Table 3 Correlation between CIMT and FMD% measurements in RA patients and clinical and laboratory parameters.
Variables CIMT FMD%
Correlation coeﬃcient P-value Correlation coeﬃcient P-value
Age +0.153 <0.05 (S) 0.079 NS
Disease duration +0.196 <0.05 (S) 0.052 NS
BMI +0.39 NS 0.027 NS
Systolic blood pressure +0.258 <0.05 (S) 0.197 NS
Diastolic blood pressure +0.104 NS 0.081 NS
HAQ +0.81 <0.05 (S) 0.039 NS
DAS +0.241 <0.05 (S) 0.026 NS
CRP +0.209 <0.05 (S) 0.028 NS
ESR 0.073 NS 0.035 NS
Total cholesterol +0.181 NS 0.015 NS
HDL-c 0.489 <0.05 (S) +0.024 NS
LDL-c +0.179 NS 0.013 NS
Triglycerides +0.118 NS 0.019 NS
NS = not statistically signiﬁcant, S = statistically signiﬁcant.
Table 4 Relationship between CIMT (dependent variable) and brachial artery FMD% (continuous variable) in RA patients.
Model b coeﬃcient Standard error P-value
Model 1 (unadjusted) 0.2341 0.1459 0.268 (>0.05)
Model 2 (adjusted for age and sex) 0.2132 0.1479 0.216 (>0.05)
Model 3 (full mode) 0.2054 0.1846 0.387 (>0.05)
Full model adjusted for age, sex, duration of the disease, systolic blood pressure, CRP, DAS and HDL-c.
a b
c
D0 D1
Fig. 3 Normal control female aged 40 years with normal FMD= 10.86% (a, b) & normal CIMT= 0.4 mm (c) D0 (Baseline diameter
of the brachial artery) and D1 (post-occlusion diameter of the brachial A).
Measurement of FMD% and CIMT by high resolution B-mode ultrasound 93Also Fan et al. (10) conﬁrmed our results and stated that at
the univariate analysis, a signiﬁcantly positive correlation was
observed between CIMT and age of the patients, diseaseduration, DAS, CRP and systolic blood pressure and a statis-
tically inverse correlation was observed between CIMT and
HDL-cholesterol. Adhikari et al. (19) supported our results
a b
c
D0 D1 
Fig. 4 Rheumatoid arthritis female patient aged 42 years with low FMD= 6.38% (a, b) & high CIMT= 1.3 mm (c).
a b
D0 D1
c
Fig. 5 Rheumatoid arthritis female patient aged 47 years with low FMD= 3.22% (a, b) & high CIMT= 1.0 mm (c).
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a b
D0 D1
c
DistA          1.3 mm
DistA          2.5 mm DistA          2.8 mm
Fig. 6 Rheumatoid arthritis female patient aged 46 years with normal FMD= 12% (a, b) & high CIMT= 1.3 mm (c).
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and swollen joint count had signiﬁcant correlations with
patient’s CIMT.
Also the results reported by Targon´ska-Stepniak (22) are
consistent with us who stated that in RA patients, CIMT cor-
related positively with a number of immunological and inﬂam-
matory parameters and also with amino-terminal pro-brain
natriuretic peptide (NT-proBNP), age, and metabolic variables
(serum cholesterol, creatinine, cystatin C). In multiple linear
regression analysis, signiﬁcant association was found between
CIMT and NT-proBNP and age. Patients without atheroscle-
rosis (CIMT< 0.6 mm) were younger and had signiﬁcantly
lower concentrations of NT-proBNP and total cholesterol, as
well as higher estimated glomerular ﬁltration rate. The course
of RA in patients without atherosclerosis was characterized by
shorter disease duration, lower tender joint count, and C-reac-
tive protein.
In our study we found that FMD% was signiﬁcantly lower
in rheumatoid arthritis patients compared to those of the
healthy controls. These ﬁndings are similar to those reported
in other studies (10,19). Low FMD% in our RA patients con-
ﬁrms results from previous studies who assessed the endothe-
lial function in similar patients, which also showed that
FMD% was associated with classical risk factors, such as
hyperlipidaemia and systolic blood pressure (9,18), however,
in our study, we found that FMD% had no association with
any of these risk factors but this ﬁnding needs conﬁrmation
in a larger sample size as the atherosclerosis is a complex pro-
cess and at different stages there may be different factors cor-
relating with FMD%.AbdelMaboud and Elsaid (18) demonstrated that FMD
and CIMT are promising methods for the evaluation of RA
and are very helpful for the prevention of vascular risk, how-
ever this study did not investigate a correlation between mea-
surements of CIMT and brachial artery FMD% in RA
patients.
In the current study, we did not ﬁnd correlation between
measurements of CIMT and brachial artery FMD% in RA
patients. This may be owed to the techniques used in making
themeasurements of FMD%andCIMT.However, bothCIMT
and endothelial function measurements were performed by the
same experienced radiologist and following common standard-
ized protocols, which suggest that our techniques of measure-
ments are accurate. Therefore, we believe that our ﬁndings
support the other possibility that in RA patients with relatively
few risk factors, CIMT and brachial artery FMD% provide
independent information about the atherosclerotic process.
These ﬁndings are in agreement with Fan et al. (10) who
stated that there is no correlation between measurements of
CIMT and brachial artery FMD% in cohort RA patients
without CVD and with relatively few risk factors. Also they
reported that atherosclerosis is a complex disease and may
have complex pathways. Thus both endothelial dysfunction
and intima-media thickness may be stages in the pathogenesis
of atherosclerosis but they are in different pathways all of
which lead to clinical cardiovascular disease.
The limitations of our study were the lack of follow up of
patients over a period of time to look for clinical events like
myocardial infarction etc. and inability to comment on the
inﬂuence of drugs.
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FMD% and CIMT measured by high resolution B-mode
ultrasound are important non invasive independent imaging
methods for early prediction of the subclinical atherosclerosis
in rheumatoid arthritis patients with subsequent early treat-
ment and control of the disease vascular complications.Conﬂict of interest
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